Breast Implant-Associated Anaplastic Large Cell Lymphoma: What We Know.

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare peripheral T-cell lymphoma, first reported in 1997. It is pathologically confirmed as a CD30-positive, anaplastic lymphoma kinase ()-negative ALCL by immunohistochemistry. Unlike systemic -negative ALCL, breast implant-associated disease has a much more favorable prognosis overall.